Masahiro Kojima

Integrating Meta‐Analysis Into a Specific Study (InMASS) for Estimating the Target‐Population Average Treatment Effect

Randomized controlled trials remain the benchmark for estimating treatment effects, yet practical constraints often restrict sample sizes in a prespecified target population. In such settings, evidence from completed trials is frequently available only in aggregate form, which pr...